Friday, July 31, 2026

Nvidia’s Stock Jumps 1.46%: What Does This Mean for Their Upcoming Earnings?

Nvidia's stock rose 1.46% to $128.30 ahead of its earnings announcement, with expectations for strong results and moderated growth.

Innospace Expands U.S. Presence With New Launch Services Partnership to Target North American Small-Satellite Demand

Innospace strengthens its North American market presence by signing a launch service distribution contract with Ensemble Commercial Services.

Moscow and Pyongyang Unite: A New Treaty with an Eye on Washington

On June 19, Russia stated that the...

Tag: pharmaceutical

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

How Hanmi Pharmaceutical’s AI Platform is Revolutionizing Obesity Drug Development in 2026

Hanmi Pharmaceutical leverages AI for drug discovery, developing innovative obesity treatments and advancing to clinical trials.

How Celltrion’s Truxima Dominates the U.S. Rituximab Market: A 4-Month Winning Streak

Celltrion's Truxima leads the U.S. rituximab market for four months, gaining FDA interchangeability status, boosting growth prospects.

[Exclusive] HLB’s Liver Cancer Drug Clears Camrelizumab CMC Review, but Hengrui Manufacturing Facility Becomes New Hurdle

HLB's liver cancer drug approval faces delays due to FDA findings at Hengrui's facility, despite resolution of previous issues.

Centellian24 ranks No. 1 in PDRN eye cream category at U.S. Amazon Prime Day

Centellian24 by DongKook Pharmaceutical topped Amazon's eye cream category during Prime Day, with sales up over 900% from last year.

Discover the New Turbineu Double Action Aerosol: The Ultimate Solution for Athlete’s Foot in 2026

Dong-A Pharmaceutical has launched 'Turbinew Double Action Aerosol', an easy-to-use spray treatment for athlete's foot.

Samsung Bioepis Signs Teva Deal to Commercialize Opuviz in Canada, Expanding North American Biosimilar Business

Samsung Bioepis partners with Teva to launch ophthalmology biosimilar Opuviz in Canada, enhancing access to treatments for patients.

SK Bioscience Achieves WHO PQ Certification: What This Means for Global Vaccine Supply

SK Bioscience completed WHO's triennial review for its vaccines, enhancing international trust in its quality and operational systems.

Mexico Recognizes South Korea’s MFDS: What This Means for Drug Approvals

Mexico recognizes South Korea's MFDS as a reference authority, streamlining drug approvals and enhancing market access for Korean firms.

ViOL Medical Expands China Push With New Sylfirm X Supply Deal With Sihuan Pharmaceutical

ViOL Medical expands its partnership with Sihuan Pharmaceutical to enhance the market presence of its Sylfirm X device in China.

Samjin Pharmaceutical and Aribio Lab Form Vaccine Partnership to Advance Joint Development and Commercialization

Samjin Pharmaceutical partners with Aribio Lab to develop and commercialize vaccines, enhancing market adoption and R&D capabilities.

Onconic Therapeutics Expands Zaqbo Development in China With Phase 3 Trial for H. pylori Eradication

Onconic Therapeutics' Zaqbo enters Phase 3 trials in China for H. pylori eradication, with strong revenue growth reported.

DongKoo Bio & Pharma Unveils TERABIOTICS PRO 1.06 to Strengthen Health Supplement Business

Donggu Bio Pharmaceutical announces the launch of its new 5th generation probiotic product, TERABIOTICS PRO 1.06.

AriBio Advances Global Alzheimer’s Strategy With Multibillion-Dollar AR1001 Licensing Deal

AriBio secures a $4.67 billion licensing deal for Alzheimer's drug AR1001 with Puxing Pharmaceutical, aiming for global commercialization.

A Record Year in China Is Giving Hanmi Pharmaceutical More Firepower for What’s Next

Hanmi Pharmaceutical's Chinese subsidiary surpassed $290M in sales, contributing significantly to the group's growth and future investments.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.